Name of Resource

    C. elegans ND Models (CRCHUM - Universite de Montreal)

    Name of Principal Investigator - Title

    Dr

    Name of Principal Investigator - First name

    Alex

    Name of Principal Investigator - Last name

    Parker

    Address of institution -Institution

    CRCHUM - Universite de Montreal

    Address of institution - Street address

    Address of institution - City

    Montreal

    Address of institution - Postcode

    Country

    Canada

    Website
    Contact email
    Summary

    C. elegans models of neurodegeneration

    Q1a. Please indicate below if your cohort includes or expects to include, incidence of the following conditions? (1)

    Motor neurone diseases| Alzheimer's disease and other dementias| Neurodegenerative disease in general

    Q1b. Does your resource hold

    Animals| Genetic Material (e.g. DNA, RNA, vectors)

    Q2a. Does the resource act as a centre for access and distribution to external groups (who are not the Principal Investigators (PI) for the resource)?

    Yes

    Q2b. If Yes, what procedures and rules apply for access?

    Apply to PI or co-ordinator at resource| Access independent of collaboration with PI

    Q3a. Does your resource develop experimental models (animal/cell) for external groups?

    Yes

    Q3b. If YES and your resource is related to an ANIMAL model, what types of models are provided?

    Wild type| Genetically Modified| Humanised

    Q3c. If YES and your resource is related to a CELL model, what types of models are provided?

    Q4a. Is this activity supported as:

    Q4b. Do you deposit what you supply in any kind of central repository?

    Disease

    ALS| HD| PD

    Species

    C.elegans| C.elegans| C.elegans

    Available to external user

    Yes| No| No

    Full phenotypic character

    Yes| Yes| Yes

    Please indicate the phenotypes

    Motor neuron degeneration| Neuronal dysfunction| Dopaminergic neuron degeneration

    List of genotypes or other subtypes

    Q5b. Cognitive function, No of models

    Q5b. Cognitive function, Available to external users

    Q5b. Cognitive function, Full phenotypic characterisation

    Q5b. Cognitive function, Nature of phenotype

    Q5b. Motor function, No of models

    5

    Q5b. Motor function, Available to external users

    Yes

    Q5b. Motor function, Full phenotypic characterisation

    Yes

    Q5b. Motor function, Nature of phenotype

    Degenerating motor neurons

    Q5b. Physiological function, no of models

    Q5b. Physiological function, Available to external users

    Q5b. Physiological function, Full phenotypic characterisation

    Q5b. Physiological function, Nature of phenotype

    Q5b. Other function (please specify), no of models

    Please specify other function

    Q5b. Other function (please specify), Available to external users

    Q5b. Other function (please specify), Full phenotypic characterisation

    Q5b. Other function (please specify), Nature of phenotype

    Q6. Please indicate if your resource is already linked into European or international consortia or networks?

    Q7a. Is maintenance of this resource dependent on continued funding?

    No

    Q7b. If yes, when does the current funding period end?

    Q7c. What is the expected lifespan of the resource (in years)?

    Indefinite, can be frozen

    Q7d. Are there other plans affecting future use that it may be useful to know?

Types: Experimental Models
Member States: Canada
Diseases: N/A
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF